• Return to Headlines

Alder Biopharmac Shares Down 22.1% Since SmarTrend's Sell Call (ALDR)

By David Diaz

SmarTrend identified a Downtrend for Alder Biopharmac (NASDAQ:ALDR) on September 18th, 2018 at $16.73. In approximately 3 weeks, Alder Biopharmac has returned 22.09% as of today's recent price of $13.03.

Over the past year, Alder Biopharmac has traded in a range of $9.55 to $20.87 and is now at $13.03, 36% above that low. The 200-day and 50-day moving averages have moved 0.34% higher and 2.11% lower over the past week, respectively.

Alder Biopharmaceuticals, Inc. provides pharmaceutical products and services. The Company identifies, develops, and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular, and autoimmune and inflammatory disease areas. Alder Biopharmaceuticals operates in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Alder Biopharmac.

Log in and add Alder Biopharmac (ALDR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights alder biopharmac

Ticker(s): ALDR